Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.98 USD | +1.11% | +4.06% | -5.84% |
05-15 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
05-15 | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
- Stock Market
- Equities
- GMAB Stock
- GMAB Stock
- News Genmab A/S
- Other languages